2 results
Approved WMORecruiting
Primary ObjectivesEvaluate the efficacy of pemigatinib versus gemcitabine plus cisplatin in the first-line treatment of participants with cholangiocarcinoma with FGFR2 rearrangement. Secundary ObjectivesEvaluate the efficacy of pemigatinib versus…
Approved WMORecruiting
To evaluate the long-term safety and tolerability of TAK-861.